I-Mab (NASDAQ:IMAB) Q2 2023 Earnings Call Transcript August 17, 2023 Tyler Ehler: Good morning, everyone, and thank you for joining us this morning and for standing by. I’d like to take this opportunity to welcome you all to the I-Mab Biopharma Mid-Year 2023 Financial Results and Business Update Conference Call. My name is Tyler Ehler, […]